SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001250853-18-000150
Filing Date
2018-12-11
Accepted
2018-12-11 19:49:00
Documents
1
Period of Report
2018-12-07

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 6761
  Complete submission text file 0001250853-18-000150.txt   8503
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Issuer) CIK: 0001335105 (see all company filings)

IRS No.: 202903526 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4852 SAINT ANDRES AVE. LA VERNE CA 91750
Business Address
Riggs Arthur (Reporting) CIK: 0001557190 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51476 | Film No.: 181229873

Mailing Address 4852 SAINT ANDRES AVENUE LA VERNE CA 91750
Business Address
Riggs Jane Merrill (Reporting) CIK: 0001608723 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51476 | Film No.: 181229874